Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors

被引:89
作者
Liang, TJ
Reid, AE
Xavier, R
Cardiff, RD
Wang, TC
机构
[1] MASSACHUSETTS GEN HOSP,GASTROINTESTINAL UNIT,DEPT MED,BOSTON,MA 02114
[2] MASSACHUSETTS GEN HOSP,CTR CANC,BOSTON,MA 02114
[3] HARVARD UNIV,SCH MED,BOSTON,MA 02114
[4] UNIV CALIF DAVIS,SCH MED,DEPT PATHOL,DAVIS,CA 95616
关键词
c-met; hepatocyte growth factor; receptor tyrosine kinase; carcinogenesis; sarcoma;
D O I
10.1172/JCI118744
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Receptor tyrosine kinases are important in cell signal transduction and proliferation, Abnormal expression of tyrosine kinases often leads to malignant transformation, C-met is a tyrosine kinase receptor and its ligand is hepatocyte growth factor (HGF), HGF/c-met plays diverse roles in regulation of cell growth, shape and movement. Constitutively activated met, such as tpr-met, is a potent oncogene in vitro, but its carcinogenic role in vivo remains unclear, Our study demonstrates that expression of tpr-met leads to development of mammary tumors and other malignancies in transgenic mice, and suggests that deregulated met expression may be involved in mammary carcinogenesis.
引用
收藏
页码:2872 / 2877
页数:6
相关论文
共 26 条
[1]   MULTIPLE INDEPENDENT ACTIVATIONS OF THE NEU ONCOGENE BY A POINT MUTATION ALTERING THE TRANSMEMBRANE DOMAIN OF P185 [J].
BARGMANN, CI ;
HUNG, MC ;
WEINBERG, RA .
CELL, 1986, 45 (05) :649-657
[2]   LOSS OF HETEROZYGOSITY ON CHROMOSOME-7Q AND AGGRESSIVE PRIMARY BREAST-CANCER [J].
BIECHE, I ;
CHAMPEME, MH ;
MATIFAS, F ;
HACENE, K ;
CALLAHAN, R ;
LIDEREAU, R .
LANCET, 1992, 339 (8786) :139-143
[3]   IDENTIFICATION OF THE HEPATOCYTE GROWTH-FACTOR RECEPTOR AS THE C-MET PROTOONCOGENE PRODUCT [J].
BOTTARO, DP ;
RUBIN, JS ;
FALETTO, DL ;
CHAN, AML ;
KMIECIK, TE ;
VANDEWOUDE, GF ;
AARONSON, SA .
SCIENCE, 1991, 251 (4995) :802-804
[4]  
CAPETANAKI Y, 1990, ONCOGENE, V5, P645
[5]  
CARDIFF RD, 1991, AM J PATHOL, V139, P495
[6]  
CHAN AML, 1987, ONCOGENE, V1, P229
[7]  
COMOGLIO PM, 1993, HEPATOCYTE GROWTH FA, V5, P131
[8]  
FALETTO DL, 1993, HEPATOCYTE GROWTH FA, P107
[9]  
GHERARDI E, 1991, CANCER CELL-MON REV, V3, P227
[10]  
GRIGIONI WF, 1995, HEPATOLOGY, V21, P1543, DOI 10.1016/0270-9139(95)90457-3